Gene Editing of Stem Cells for Universal Cell Therapy - Joanna Brewer

• Date : 19/05/2018
• 0    
  0

Development and Regulation of Immunotherapy - Klaus Cichutek

• Date : 19/05/2018
• 0    
  0

Economic and Commercial Bases for Pricing of Genetic Therapies - Eric Auger

• Date : 19/05/2018
• 0    
  0

Electroporation-mediated Gene Delivery to the Heart for Coronary Artery Disease - Richard Heller

• Date : 19/05/2018
• 0    
  0

Engineered T cells for Cancer Therapy in 2018 - Saar Gill

• Date : 19/05/2018
• 0    
  0

Engraftment and Phenotypic Correction of Hematopoietic Stem Cells in Fanconi Anemia Patients

• Date : 19/05/2018
• 0    
  0

Ethics: from Clinical Trials to Products - Jonathan Kimmelman

• Date : 19/05/2018
• 0    
  0

Fundamentals of T cell-based Immunotherapy - Nicholas Restifo

• Date : 19/05/2018
• 0    
  0

Gene Correction at Targeted DNA Nicks - Nancy Maizels

• Date : 19/05/2018
• 0    
  0

Developing Non-viral/Nanoparticle Gene Delivery for Retinal Degeneration - Muna Naash

• Date : 19/05/2018
• 0    
  0

Gene Therapy for X-Linked Chronic Granulomatous Disease - Donald Kohn

• Date : 19/05/2018
• 0    
  0

Genome Editing in Human Stem Cells for Blood Disease Modeling and Treatment - Linzhao Cheng

• Date : 19/05/2018
• 0    
  0

History of CAR Approval and Next Generation CARs - Carl June

• Date : 19/05/2018
• 0    
  0

How Pharma Establishes Prices of Genetic Therapies - Jason Meyenburg

• Date : 19/05/2018
• 0    
  0

Immunogenicity of AAV Vectors and Transgenes - Roland Herzog

• Date : 19/05/2018
• 0    
  0

In Utero Gene Correction Mediated by PNA-Nanoparticles - Adele Ricciardi

• Date : 19/05/2018
• 0    
  0

Inducing Immune Tolerance with Liver-directed Expression by AAV - Dwight Koeberl

• Date : 19/05/2018
• 0    
  0

Cardiac Regeneration - Amit Patel

• Date : 19/05/2018
• 0    
  0

A Phase I Clinical Trial of Malignant Pleural Disease Treated...Prasad Adusumilli

• Date : 19/05/2018
• 0    
  0

AAV Gene Therapy to CNS: Past, Present and Future - Miguel Sena-Esteves

• Date : 19/05/2018
• 0    
  0

AAV Vectors in the Eye - Shannon Boye

• Date : 19/05/2018
• 0    
  0

AAV Vectors in the Liver - Ian Alexander

• Date : 19/05/2018
• 0    
  0

Adipose Stromal Cell Therapy for Osteoarthritis of the Knee - Frank Barry

• Date : 19/05/2018
• 0    
  0

Ancestral AAV Capsid Reconstruction: Interrogating Viral Evolution to Inform Rational AAV Design

• Date : 19/05/2018
• 0    
  0

Autologous Tgf?-Resistant HPV-16/18 E6/E7-Specific T Lymphocytes...for the Treatment of Cancers

• Date : 19/05/2018
• 0    
  0

Bioethics of Genome Editing - Silvia Camporesi

• Date : 19/05/2018
• 0    
  0

Induction of HbF to Treat ?-hemoglobinopathies- Bringing CRISPR to the Clinic - Tony Ho

• Date : 19/05/2018
• 0    
  0

Cell Therapeutics for Pulmonary Disease - Daniel Weiss

• Date : 19/05/2018
• 0    
  0

Clinical Electrochemotherapy and Gene Electrotransfer for Tumor Treatment - Maja Cemazar

• Date : 19/05/2018
• 0    
  0

Clonal Tracking of Genetically Engineered Hematopoietic Cells in Humans - Luca Biasco

• Date : 19/05/2018
• 0    
  0

CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients in hiPSC-derived Muscle

• Date : 19/05/2018
• 0    
  0

Decrease in B-Lymphocyte Levels...Reduces the Efficacy of Autologous Bone Marrow Cell Therapy

• Date : 19/05/2018
• 0    
  0

Design and Translational Application of HSV Gene Vectors in Nervous System Diseases

• Date : 19/05/2018
• 0    
  0

Design, Formulation and Testing of Systemically Dosed Peptide and Polymer DNA and mRNA Nanoparticles

• Date : 19/05/2018
• 0    
  0

Thalassemia Clinical Trials - Alexandria Petrusich

• Date : 19/05/2018
• 0    
  0

Reprogramming Human T Cell Circuitry - Alexander Marson

• Date : 19/05/2018
• 0    
  0

Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa - Henry Klassen

• Date : 19/05/2018
• 0    
  0

SCID Immunodeficiency Trial - Brian Sorrentino

• Date : 19/05/2018
• 0    
  0

Seeing the Light with Retinal Gene Therapy: From Fantasy to Reality - Jean Bennett

• Date : 19/05/2018
• 0    
  0

Small RNAs for Cardiac Gene Editing and Regeneration - Mauro Giacca

• Date : 19/05/2018
• 0    
  0

Sticker Shock: How to Purchase a CAR - Carl June

• Date : 19/05/2018
• 0    
  0

Structure-Function Relationship in Chimeric Antigen Receptors - Maksim Mamonkin

• Date : 19/05/2018
• 0    
  0

Targeting Onco-microRNA Dependence of Malignant Glioma by Gene Editing - Anna Krichevsky

• Date : 19/05/2018
• 0    
  0

Regulatory T-cells for Inducing Tolerance to FVIII - Carol Miao

• Date : 19/05/2018
• 0    
  0

The Challenge to Develop and Commercialize Gene-Based Therapies for Rare Diseases

• Date : 19/05/2018
• 0    
  0

Translating RNAi for Huntington’s Disease - Megan Keiser

• Date : 19/05/2018
• 0    
  0

Transplantation and Persistence of CRISPR/Cas9-Edited Hematopoietic Stem and Progenitors Cells

• Date : 19/05/2018
• 0    
  0

Treatment of Recurrent HGG Patients with the Retroviral Replicating Vector Toca 511 and Toca FC

• Date : 19/05/2018
• 0    
  0

Turning Genes into Medicines: Therapeutics for the New Millenium - Katherine High

• Date : 19/05/2018
• 0    
  0

Update on Phase I/II Clinical Trial of Intracerebral Administration of rAAV2/5hNAGLU Vector

• Date : 19/05/2018
• 0    
  0

Viral Infections in Transplantation - Ann Leen

• Date : 19/05/2018
• 0    
  0

Update on Phase I/II Clinical Trial for Ornithine Transcarbamylase (OTC) Deficiency Using AAV

• Date : 19/05/2018
• 0    
  0

Reducing the Immunogenicity of AAV through Engineering the Vector - George Church

• Date : 19/05/2018
• 0    
  0

Reconciling the Stem/Progenitor and Paracrine Functions of MSCs - Donald Phinney

• Date : 19/05/2018
• 0    
  0

Readministration of AAV vector in Pompe Disease - Manuela Corti

• Date : 19/05/2018
• 0    
  0

Pluripotent Cell-Derived NK Cells as a Cornerstone Approach for Off-the-Shelf Cancer Immunotherapy

• Date : 19/05/2018
• 0    
  0

Phase III Trial for Treatment of Cervical Dysplasia Caused by Human Papillomavirus - Mark Bagarazzi

• Date : 19/05/2018
• 0    
  0

Phase I/II Clinical Trial for Recessive Dystrophic Epidermolysis Bullosa Using EB-101 - J.Y. Tang

• Date : 19/05/2018
• 0    
  0

Patient Issues and Opportunities for Fair Access to Gene-based Therapies in Rare Disease

• Date : 19/05/2018
• 0    
  0

Panel Discussion

• Date : 19/05/2018
• 0    
  0

Next-generation Approaches for Rapid Production of Nanoparticles for Use in Gene and Cell Therapies

• Date : 19/05/2018
• 0    
  0

Nucleic Acid Delivery Systems for RNA Therapy and Gene Editing - Daniel Anderson

• Date : 19/05/2018
• 0    
  0

Noninvasive Imaging Technologies to Monitor Biodistribution, Activity, and Toxicity of Viruses

• Date : 19/05/2018
• 0    
  0

New AAVs for Sensory Organ Targeting - Casey Maguire

• Date : 19/05/2018
• 0    
  0

New AAVs for Central Nervous System Targeting - David Schaffer

• Date : 19/05/2018
• 0    
  0

MR Image-Guided Transfection of the CNS with Focused Ultrasound and Brain-Penetrating Nanoparticles

• Date : 19/05/2018
• 0    
  0

Melanoma Skin Trial - Robert Andtbacka

• Date : 19/05/2018
• 0    
  0

13ème Assises de Génétiques Humaine et Médicale 2025

• Date : 27/01/2026
• 758    
  0

ASHG Conférence Annuelle 2025

• Date : 14/10/2025
• 1412    
  0

28ème Congrès annuel de l'American Society of Gene & Cell Therapy - ASGCT 2025

• Date : 13/05/2025
• 1003    
  0

51ème Congrès Annule de l'EBMT

• Date : 30/03/2025
• 1092    
  0

Empowering patients 2025 : un sommet de l'American Society of Gene and Cell Therapies – ASGCT 2025

• Date : 12/03/2025
• 752    
  0